Pancreatitis in patients treated with brentuximab vedotin: A previously unrecognized serious adverse event Journal Article

   

Authors:	Gandhi, M. D.; Evens, A. M.; Fenske, T. S.; Hamlin, P.; Coiffier, B.; Engert, A.; Moskowitz, A. J.; Ghosh, N.; Petrich, A. M.; Lomasney, J.; Chadburn, A.; Wood, G. S.; Salva, K.; Nardone, B.; Trifilio, S. M.; Raisch, D. W.; West, D. P.; Gordon, L. I.; Winter, J. N.
Article Title:	Pancreatitis in patients treated with brentuximab vedotin: A previously unrecognized serious adverse event
Keywords:	immunohistochemistry; adult; treatment outcome; aged; middle aged; young adult; clinical feature; antineoplastic agents; letter; antigen expression; demography; nausea; hodgkin disease; abdominal pain; pancreatitis; lymphoma; autopsy; triacylglycerol lipase blood level; fatal outcome; triacylglycerol lipase; cd30 antigen; fatality; lymphoma, large-cell, anaplastic; immunoconjugates; brentuximab vedotin; humans; human; male; female; priority journal
Journal Title:	Blood
Volume:	123
Issue:	18
ISSN:	0006-4971
Publisher:	American Society of Hematology
Date Published:	2014-01-01
Start Page:	2895
End Page:	2897
Language:	English
DOI:	10.1182/blood-2014-03-561878
PUBMED:	24786458
PROVIDER:	scopus
PMCID:	PMC4007615
DOI/URL:	http://www.scopus.com/inward/record.url?eid=2-s2.0-84903139938&partnerID=40&md5=03a04ffba2204e6b3df10b3aa8b14ff3
Notes:	Export Date: 1 August 2014 -- CODEN: BLOOA -- Source: Scopus

https://synapse.mskcc.org/synapse/works/has_related_data_chk/55014